COVID-19

Patients administered anakinra did not meet a study’s primary endpoint of proportion of patients who did not need mechanical ventilation 15 days after starting treatment for severe COVID-19 pneumonia.

The role of monoclonal antibodies in minimizing COVID-19–related complications remains important to assess.

Among those without HIV, the analyses found that respondents with a history of COVID-19 performed worse on processing speed than those who had never had COVID-19.

The disease is the continuation of new symptoms 3 months after the initial SARS-CoV-2 infection and at least lasting 2 months after infection, according to the health organization.

Investigators analyze to see if there was an association of expected benefits and risk of vaccination.

This drug is the first to control complement factor C5a, which is a protein that plays a significant but potentially harmful role in the body's immune response.

Pharmacies need to differentiate themselves through faster and cheaper care, while delivering health outcomes across the patient journey.

Increased risk for severe disease in individuals with SUD could be from co-occurring medical conditions, investigators from Boston Medical Center say.

The pandemic was eye-opening for many pharmacists, and one expert reflects on recognizing the importance of the pharmacy technician and accessible healthcare.

Pharmacists on duty decline to dispense the medication to manage COVID-19, raising question about self-determination.

Michael D. Hogue, PharmD, FAPhA, FNAP, FFIP, discusses current outlook on the occurrence of outbreaks of vaccine-preventable diseases in the country.

As the risk of respiratory depression is elevated with opioid use, the risk of complications from COVID-19 is increased in patients with opioid use disorder.

The COVID-19 pandemic marginally affected the negative mental health of women more than men, according to a new study.

Investigators estimate that the effectiveness was higher after 1 or 2 booster doses compared with the primary series alone.

Atea’s drug candidate is considered safe and effective against the viruses that cause COVID-19 and hepatitis C, according to new data presented at ICAR 2023.

Emotional support greatly improved symptoms of psychological distress from the pandemic among pregnant women.

Staff members, especially immunizers, should look at every encounter as an opportunity to educate, support patients.

The risk of long COVID-19 was no worse for patients who had Omicron after the wild-type virus than those just diagnosed with the wild-type.

Among the participants who were initially unsure or hesitant about vaccination, 82% received flu and Tdap vaccines during pregnancy after the online intervention.

Study includes healthy individuals and those who had progressive multiple sclerosis with the nasally administered treatment.

The fourth dose of the bivalent vaccine elicited improved Omicron BA.4/BA.5-neutralizing antibody responses compared to participants who received 3 doses of the original vaccine.

Nightlife transmission of COVID-19 affected a larger number of younger individuals but caused fewer household outbreaks in 2020.

The efficacy of 2 doses against Omicron infection was highest when the second vaccine dose was given in the third trimester of pregnancy compared with the first or second trimesters.

Due to the success of mRNA technology with COVID-19, there has been a significant increase in research looking into utilizing mRNA technology, and more specifically, how it can help to advance vaccine development.

The effectiveness of 2 doses against Omicron infection was highest when the second dose was given in the third trimester of pregnancy compared with the first or second trimesters.

Companies seek FDA approval for individuals aged 12 years and older to receive vaccinations for their primary series.

Patients who had relapsed or treatment-resistant cancer at baseline, or those who had more severe acute COVID-19 infections, were less likely to develop long COVID-19.

The COVID-19 and flu test is a single-use at-home test kit that uses self-collected nasal swab samples and provides results in approximately 30 minutes.

Results of the ACTIV-6 study showed that high dose ivermectin use did not demonstrate a clinical benefit for mild to moderate COVID-19.

In a subgroup analysis, patients with COVID-19 who received conventional oxygen support also benefitted, having 20 fewer deaths per 1000 patients when given remdesivir.